أجريت الدراسة لتقييم كفاءة البروكالسيتونين في تشخيص الإنتان الجرثومي عند مرضى السرطان في مركز المعالجة الكيماوية و الشعاعية في مشفى تشرين الجامعي باللاذقية في الفترة الواقعة بين 3\1\2015 إلى 28\3\2016.
شملت الدراسة (45) مريضاً كان منهم (25) مريض انتان مثبت و (20) مريض انتان غير مثبت، و جميعهم لديهم حمى و غير متناولين للصادات الحيوية حيث خضع المرضى لتقييم بدئي شامل تضمن فحص سريري دقيق و فحوص مخبرية عديدة و صور شعاعية كما تم قياس البروكالسيتونين أثناء الترفع الحروري و مقارنته مع البروتين المتفاعل C، و أشارت النتائج الى وجود ارتباط هام بين البروكالسيتونين و الانتان حيث كانت القيم الوسطية للبروكالسيتونين عند مرضى الانتان المثبت 16.9 نغ/مل مقابل 0.7 نغ/مل عند مرضى الانتان غير المثبت، كما ترافق ازدياد تركيز البروكالسيتونين مع زيادة شدة الانتان، و اظهرت الدراسة أن البروكالسيتونين أكثر حساسية و نوعية من ال CRP في تشخيص وجود انتان عند مرضى السرطان.
The study is carried out to estimate the efficiency of Procalcitonin in the diagnosis of
bacterial infection in cancer patients at Chemical and Radiation Therapy Center in
Tishreen University Hospital in Lattakia between 3/1/2015-28\3\2016.
This study has included 45 patients, 25 with infection and 20 without infection, all of
them have a fever and don't take antibiotics. The all of patients has undergone a
comprehensive initial assessment included history, physical examination, biochemical
parameters and X-ray images.
Procalcitonin was also measured during fever and compared with C-reactive protein
CRP, the results indicated that there is a significant correlation between Procalcitonin and
infection, where the median values Procalcitonin in patients with infection 16.9 ng/ml
compared to 0.7 ng/ml in patients without infection, Procalcitonin concentration was also
associated with the severity of the infection, the study showed that the Procalcitonin is
more sensitive and specific of the CRP in diagnosing of sepsis in cancer patients.
References used
LE MOULLEC J.M, JULLIENNE A, CHENAIS J, LASMOLES F, GULIANA J.M, MILHAUD G, et al. The complete sequence of human preprocalcitonin. FEBS 1984, 167: 93-97
NYLEN E.S, SNIDER R.H, THOMPSON K.A., ROHATGI P, BECKER K.L. Pneumonitis-associated hyperprocalcitoninemia. Am J Med Sci 1996, 312: 12-18
LINSCHEID P, SEBOEK D, NYLEN E.S, LANGER I., SCHLATTER M, KELLER U, BECKER K.L. and MÜLLER B. In vitro and in vivo calcitonin-I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinol 2003,144, 5578-5584
Background: cancer patients experience large physical and emotional challenges
related to side effects of chemotherapy drugs, which make coping and adaptation essential
issue for coping with disease. Aim: this study was conducted to identify coping
Fatigue is one ofthemostimportant and common side effectamong cancer patient
under chemotherapy. Objective:the study aimed is to study the effect back, hand and foot
massage on fatigue levelto cancer patient under chemotherapy.Material and method:t
Oral complications are common in patients with cancer who
undergo chemotherapy treatment. Not all patients are at equal risk
for developing oral complications. A number of variables have been
identified that bear on both the frequency and severity
Lung cancer is the major cause of cancer death. S100A7
overexpression has been associated with early stages of
carcinomas . This study aimed to evaluate the levels of serum
S100A7 in lung cancer. Our study contains 63 patients of lung
cancer (46
Cancer alone kills 7.6 million people every year. According to World Health Organization (WHO) estimates, cancer deaths in the Eastern Mediterranean Region will increase from 9.4% in 2015 to 12.3% in 2030 of all deaths. These estimates are based on t